BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1927238)

  • 21. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
    Botte L; Bienfait J; Dethier J; Even P; Evrard JL; Fraipont J; Goffin L; Willemse P
    Acta Psychiatr Belg; 1981; 81(6):595-608. PubMed ID: 6125089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo.
    Greenblatt DJ; Harmatz JS; Dorsey C; Shader RI
    Clin Pharmacol Ther; 1988 Sep; 44(3):326-34. PubMed ID: 3138056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The cognitive effect of alprazolam in healthy volunteers].
    Drabant S; Tömlo J; Tóth M; Péterfai E; Klebovich I
    Acta Pharm Hung; 2006; 76(1):25-31. PubMed ID: 17094673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lorazepam on fear-potentiated startle responses in man.
    Graham SJ; Scaife JC; Langley RW; Bradshaw CM; Szabadi E; Xi L; Crumley T; Calder N; Gottesdiener K; Wagner JA
    J Psychopharmacol; 2005 May; 19(3):249-58. PubMed ID: 15888510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS; Woods SW
    J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative evaluation of the effects of oral lorazepam, alprazolam and diazepam on venous admixture.
    Naqib A; Mir B; Beigh A
    J Assoc Physicians India; 2002 Mar; 50():387-90. PubMed ID: 11922228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of lorazepam on visual perceptual abilities.
    Pompéia S; Pradella-Hallinan M; Manzano GM; Bueno OF
    Hum Psychopharmacol; 2008 Apr; 23(3):183-92. PubMed ID: 18318455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
    Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
    Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam.
    Snyder PJ; Werth J; Giordani B; Caveney AF; Feltner D; Maruff P
    Hum Psychopharmacol; 2005 Jun; 20(4):263-73. PubMed ID: 15912482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A neurophysiological study of the detrimental effects of alprazolam on human action monitoring.
    Riba J; Rodríguez-Fornells A; Münte TF; Barbanoj MJ
    Brain Res Cogn Brain Res; 2005 Oct; 25(2):554-65. PubMed ID: 16168630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive indices of autonomic regulation after alprazolam and lorazepam: effects on sympathovagal balance.
    Tulen JH; Man in't Veld AJ
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):183-90. PubMed ID: 9700978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of alprazolam and lorazepam on catecholaminergic and cardiovascular activity during supine rest, mental load and orthostatic challenge.
    van den Berg F; Tulen JH; Boomsma F; Noten JB; Moleman P; Pepplinkhuizen L
    Psychopharmacology (Berl); 1996 Nov; 128(1):21-30. PubMed ID: 8944402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alprazolam and lorazepam effects on memory acquisition and retrieval processes.
    Block RI; Berchou R
    Pharmacol Biochem Behav; 1984 Feb; 20(2):233-41. PubMed ID: 6144110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interdose elevation in plasma cortisol during chronic treatment with alprazolam but not lorazepam in the elderly.
    Pomara N; Willoughby LM; Ritchie JC; Sidtis JJ; Greenblatt DJ; Nemeroff CB
    Neuropsychopharmacology; 2004 Mar; 29(3):605-11. PubMed ID: 14694352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo effects of alprazolam and lorazepam on the immune response in patients with migraine without aura.
    Covelli V; Maffione AB; Greco B; Cannuscio B; Calvello R; Jirillo E
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):415-28. PubMed ID: 8227969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel tool to quantify physical activities: ambulatory accelerometry in psychopharmacology.
    Tulen JH; Bussmann HB; van Steenis HG; Pepplinkhuizen L; Man in 't Veld AJ
    J Clin Psychopharmacol; 1997 Jun; 17(3):202-7. PubMed ID: 9169966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 1 week administration of two benzodiazepines on the sleep and early daytime performance of normal subjects.
    Jurado JL; Fernández-Mas R; Fernández-Guardiola A
    Psychopharmacology (Berl); 1989; 99(1):91-3. PubMed ID: 2506608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam.
    Bentué-Ferrer D; Reymann JM; Tribut O; Allain H; Vasar E; Bourin M
    Eur Neuropsychopharmacol; 2001 Feb; 11(1):41-50. PubMed ID: 11226811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lorazepam on deductive reasoning.
    Pompéia S; Manzano GM; Pradella-Hallinan M; Bueno OF
    Psychopharmacology (Berl); 2007 Nov; 194(4):527-36. PubMed ID: 17622517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lorazepam 0.25 mg twice a day improves aspects of psychometric performance in healthy volunteers.
    Bourin M; Colombel MC; Malinge M
    J Psychopharmacol; 1995 Jan; 9(3):251-7. PubMed ID: 22297765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.